Condition
Rubella Syndrome, Congenital
Total Trials
1
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Measlesrubella Mr Vaccine At 6 Months Of Age
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 1 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
100%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
Phase 4 (1)
Trial Status
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Measlesrubella Mr Vaccine At 6 Months Of Age1
- Measlesrubella Mr Vaccine At 9 Months Of Age1
Active Sponsors
- Centers for Disease Control and Prevention1
- International Centre for Diarrhoeal Disease Research, Bangladesh1
- Ministry of Health and Family Welfare, Bangladesh1
Top Investigators
International Centre for Diarrhoeal Disease Research, Bangladesh
Related Conditions
- Rubella1
- Measles1